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Abstract: UNLABELLED Chronic hepatitis B virus (HBV) infection remains the most common risk fac-
tor for hepatocellular carcinoma (HCC). Efficient suppression of HBV viremia and necroinflammation as
a result of nucleos(t)ide analogue treatment is able to reduce HCC incidence; nevertheless, hepatocarcino-
genesis can occur in the absence of active hepatitis, correlating with high HBV surface antigen (HBsAg)
levels. Nuclear factor ￿B (NF-￿B) is a central player in chronic inflammation and HCC development.
However, in the absence of severe chronic inflammation, the role of NF-￿B signaling in HCC development
remains elusive. As a model of hepatocarcinogenesis driven by accumulation of HBV envelope polypep-
tides, HBsAg transgenic mice, which show no HBV-specific immune response, were crossed to animals
with hepatocyte-specific inhibition of canonical NF-￿B signaling. We detected prolonged, severe endo-
plasmic reticulum stress already at 20 weeks of age in NF-￿B-deficient hepatocytes of HBsAg-expressing
mice. The unfolded protein response regulator binding immunoglobulin protein/78-kDa glucose-regulated
protein was down-regulated, activating transcription factor 6, and eIF2￿ were activated with subsequent
overexpression of CCAAT/enhancer binding protein homologous protein. Notably, immune cell infil-
trates and liver transaminases were unchanged. However, as a result of this increased cellular stress,
insufficient hepatocyte proliferation due to G1 /S-phase cell cycle arrest with overexpression of p27 and
emergence of ductular reactions was detected. This culminated in increased DNA damage already at
20 weeks of age and finally led to 100% HCC incidence due to NF-￿B inhibition. CONCLUSION The
role of canonical NF-￿B signaling in HCC development depends on the mode of liver damage; in the
case of HBsAg-driven hepatocarcinogenesis, NF-￿B in hepatocytes acts as a critical tumor suppressor by
augmenting the endoplasmic reticulum stress response. (Hepatology 2016;63:1592-1607).
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Canonical NF-jB Signaling inHepatocytes
Acts as a Tumor-Suppressor inHepatitis B
Virus Surface Antigen-Driven
Hepatocellular Carcinoma by Controlling
the Unfolded Protein Response
Yoshiaki Sunami,1,2* Marc Ringelhan,3–5* Enik€o Kokai,2 Miao Lu,1 Tracy O’Connor,4 Anna Lorentzen,4 Achim Weber,6
Ann-Katrin Rodewald,6 Beat M€ullhaupt,7 Luigi Terracciano,8 Sarah Gul,2 Sebastian Wissel,2 Frank Leith€auser,9
Daniel Krappmann,10 Petra Riedl,11 Daniel Hartmann,1 Reinhold Schirmbeck,11 Pavel Strnad,12 Norbert H€user,1 J€org Kleeff,1
Helmut Friess,1 Roland M Schmid,3 Fabian Geisler,3 Thomas Wirth,2* and Mathias Heikenwalder4,13*
Chronic hepatitis B virus (HBV) infection remains the most common risk factor for hepatocellular carcinoma (HCC).
Efﬁcient suppression of HBV viremia and necroinﬂammation as a result of nucleos(t)ide analogue treatment is able to
reduce HCC incidence; nevertheless, hepatocarcinogenesis can occur in the absence of active hepatitis, correlating with
high HBV surface antigen (HBsAg) levels. Nuclear factor jB (NF-jB) is a central player in chronic inﬂammation and
HCC development. However, in the absence of severe chronic inﬂammation, the role of NF-jB signaling in HCC
development remains elusive. As a model of hepatocarcinogenesis driven by accumulation of HBV envelope polypep-
tides, HBsAg transgenic mice, which show no HBV-speciﬁc immune response, were crossed to animals with
hepatocyte-speciﬁc inhibition of canonical NF-jB signaling. We detected prolonged, severe endoplasmic reticulum
stress already at 20 weeks of age in NF-jB-deﬁcient hepatocytes of HBsAg-expressing mice. The unfolded protein
response regulator binding immunoglobulin protein/78-kDa glucose-regulated protein was down-regulated, activating
transcription factor 6, and eIF2a were activated with subsequent overexpression of CCAAT/enhancer binding protein
homologous protein. Notably, immune cell inﬁltrates and liver transaminases were unchanged. However, as a result of
this increased cellular stress, insufﬁcient hepatocyte proliferation due to G1/S-phase cell cycle arrest with overexpres-
sion of p27 and emergence of ductular reactions was detected. This culminated in increased DNA damage already at
20 weeks of age and ﬁnally led to 100% HCC incidence due to NF-jB inhibition. Conclusion: The role of canonical
NF-jB signaling in HCC development depends on the mode of liver damage; in the case of HBsAg-driven hepatocar-
cinogenesis, NF-jB in hepatocytes acts as a critical tumor suppressor by augmenting the endoplasmic reticulum stress
response. (HEPATOLOGY 2016;63:1592-1607)
Abbreviations: ATF, activating transcription factor; BiP, binding immunoglobulin protein; CHB, chronic hepatitis B; CHOP, CCAAT/enhancer
binding protein homologous protein; ER, endoplasmic reticulum; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; HCC, hepatocellular car-
cinoma; HCV, hepatitis C virus; IHC, immunohistochemical; IKK, IjB kinase; IL-6, interleukin-6; mRNA, messenger RNA; NF-jB, nuclear factor
jB; qPCR, quantitative polymerase chain reaction; TNF, tumor necrosis factor; UPR, unfolded protein response.
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Chronic hepatitis B viral (HBV) infection is themost common chronic viral infection in theworld and, besides end-stage liver disease,
causes hepatocarcinogenesis, accounting for more than
half of all hepatocellular carcinoma (HCC) cases.(1)
HCC is the ﬁfth most common type of cancer and the
second most common cause of cancer-related death
worldwide.(2) Many patients are not eligible for cura-
tive surgical resection or liver transplantation, and
chances for curative treatment options for this chemo-
resistant tumor remain low.
In hepatocarcinogenesis a sequence of chronic
inﬂammation, cell death, compensatory liver prolifera-
tion, and subsequent liver cirrhosis as well as altered
cytokine networks and signaling pathways, including
nuclear factor jB (NF-jB) signaling, are well-
established oncogenic factors.(3-5)
It was previously shown that in HBV-induced or
hepatitis C virus (HCV)-induced hepatitis and subse-
quent inﬂammation-driven hepatocellular carcinogene-
sis, NF-jB signaling is activated(3,4) and causally
linked to the development of HCC.(5)
In persistent HBV infections, mainly an ineffective
T-cell response causes repeated liver damage.(6) Intrigu-
ingly, HCC develops in 10%-20% of patients chroni-
cally infected with HBV in the absence of cirrhosis and
severe necroinﬂammation, which is in contrast to most
other HCC etiologies.(7) Treatment with nucleos(t)ide
analogues that control HBV replication in chronic hep-
atitis B (CHB) infection greatly reduces necroinﬂam-
mation and subsequent risk of HCC development but
does not eliminate the risk for HCC, regardless of the
presence of baseline liver cirrhosis.(8) Despite efﬁcient
suppression of HBV viremia as a result of long-term
nucleos(t)ide analogue therapy, hepatocarcinogenesis is
still observed, especially in patients with high HBV
surface-antigen (HBsAg) levels.(9,10) Furthermore,
patients with spontaneous HBV DNA clearance and
residual HBsAg titers >1000 IU/mL show increased
HCC risk.(11) This is due to well-established direct
oncogenic effects of HBV, including HBV DNA inte-
gration and multiple effects of the enigmatic HBV x-
protein.(8,12) In addition, almost three decades ago, the
typical histological ﬁnding of “ground glass” hepatocytes
showing accumulation of HBV-surface proteins ﬁrst
demonstrated the direct oncogenic potential of HBsAgs
in particular situations.(13,14) Similarly, accumulation of
HBV surface proteins, overexpression of HBV large
surface proteins, preS1/2 mutants, and C-terminally
truncated M protein can be frequently found in humans
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and exert oncogenic functions.(15-17) Accumulation of
HBV surface proteins and especially large HBV surface
proteins in the endoplasmic reticulum (ER) has been
shown to induce ER stress and the unfolded protein
response (UPR) and to activate NF-jB.(13,14,18) The
UPR is activated in response to ER accumulation of
(mainly) unfolded or misfolded proteins. Activation of
the UPR eliminates misfolded proteins through ER-
associated degradation, inhibition of protein synthe-
sis,(19) or initiation of apoptosis when ER stress is sus-
tained or too severe. Sustained UPR is known to be
oncogenic, inducing DNA damage and interfering with
cell proliferation, survival, and the cell cycle.(18) A key
regulator of ER stress-associated apoptosis is CCAAT/
enhancer binding protein homologous protein
(CHOP), also known as growth arrest and DNA
damage-inducible gene 153; and unalleviated ER stress
responses induce tumor formation.(20)
Most importantly, observations in patients with
CHB under conditions of immune suppression suggest
that in the absence of adaptive immune responses, cel-
lular stress induced by HBV may also lead to develop-
ment of liver disease and carcinogenesis.(21-23)
The transcription factor NF-jB and its upstream
kinase complex IjB kinase 1 (IKK1)/IKKa, IKK2/
IKKb, and NEMO/IKKc are master regulators of cel-
lular proliferation, apoptosis, and inﬂammation which
also play a central role in hepatocarcinogenesis.(24) Sev-
eral studies demonstrate that the NF-jB system is
deregulated due to viral infection and is associated
with tumor development,(25,26) and the link between
NF-jB activation, ER stress, and liver damage is well
established.(19,27-29) Yet divergent roles of NF-jB in
hepatocarcinogenesis have been reported, depending
on the HCC model used.(24,30)
Inhibition of NF-jB signaling in hepatocytes
attenuates inﬂammation-associated HCC,(3) and
hepatic NF-jB signaling activated by lymphotoxins a
and b plays a key role in driving both virally and meta-
bolically associated hepatocarcinogenesis.(4,31) On the
other hand, liver-speciﬁc inhibition of NF-jB signal-
ing by conditional deletion of IKK2 promotes carcino-
gen (diethylnitrosamine)-induced liver cancer.(5)
Therefore, we speculated that NF-jB signaling
plays a crucial role in hepatocytes expressing high levels
of HBsAg in the absence of speciﬁc inﬂammation due
to central immune tolerance toward the transgene. To
test this theory and to determine its role in ER stress-
driven HCC development, we ablated canonical NF-
jB signaling speciﬁcally in hepatocytes of HBsAg-
overexpressing transgenic mice.
Materials and Methods
HUMAN SAMPLES
Human liver samples from patients with chronic
HBV (with or without HCC, inactive and active car-
rier state), with chronic hepatitis C viral infection, or
with nonalcoholic steatohepatitis and healthy liver
samples were obtained from the Department of Gen-
eral Surgery, MRI, TU-Munich (Munich, Germany),
Institute of Surgical Pathology (Z€urich, Switzerland),
and Institute of Pathology (Basel, Switzerland). The
project was authorized by the ethics committee at the
TU-Munich (ref: 5846/13), the University of Z€urich
(ref: StV26/2005,KEK-ZH-Nr. 2013-0382), and the
University Hospital Basel (ref: EKBB,Nr 313/13).
ANIMAL STUDIES
Transgenic mice expressing HBsAg (Tg[Alb-
lHBV]Bri44) overexpress all HBV envelope proteins
and have been described.(13,14)
In order to inhibit canonical NF-jB signaling in
hepatocytes, we crossed transgenic mice carrying a
tetracycline-inducible dominant-negative human
IKK2 (IKK2KD) allele under the control of a bidirec-
tional promoter with animals expressing tetracycline-
responsive transactivator (TET Systems) under the
control of the rat liver activator protein promoter.(32)
All mice were on a C57BL/6 and NMRI mixed back-
ground, and resulting heterozygous HBsAg1/
IKK2KDHep mice, HBsAg1 single transgenic litter-
mates, and transgenic negative control male mice were
used in this study unless otherwise speciﬁed. Mice
were kept under speciﬁc pathogen-free conditions. All
mice received 0.1 g/L doxycycline in the drinking
water until 3 weeks of age (also see Supporting
Information).
IMMUNOHISTOCHEMICAL
ANALYSIS
Histological analysis with 2 lm parafﬁn sections
was performed with the Bond Polymer Reﬁne Detec-
tion Kit (Leica) on the BondMax system (Leica).
For quantiﬁcation of stainings, whole slides were
scanned using an SCN400 slide scanner (Leica) and
analyzed using Tissue IA image analysis software
(Leica) with optimized quantiﬁcation algorithms. For
quantiﬁcation, two or three random 8-15 mm2 areas of
liver tissue on each slide were chosen, and obtained
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values were merged for further statistical analysis (also
see Supporting Information).
GENE EXPRESSION ANALYSIS
AND 16-GENE ANALYSIS
Two step real-time quantitative polymerase chain
reaction (qPCR) from whole liver/tumor tissue was
carried out using SYBR green on a Fast Real Time
PCR System (Applied Biosystems). A 16-gene analy-
sis using qPCR for characterizing liver tumors accord-
ing to their degree of proliferation and differentiation
was performed as described.(31) All real-time PCRs
were performed at least in duplicate. All values were
normalized to the level of Gapdh (or Rhot2 in 16-gene
analysis) messenger RNA (mRNA; change in cycle
threshold). The mean change in cycle threshold values
from age-matched controls was used to calculate fold
change.
WESTERN BLOTTING AND
ELECTROPHORETIC MOBILITY
SHIFT ASSAY
Western blotting and electrophoretic mobility shift
assay experiments were performed as described.(32) For
antibodies used, see Supporting Information.
HBsAg SERUM ANALYSIS
HBsAg was measured in mouse sera (1:50 dilution)
on an Architect (Abbott) using a validated two-step
HBsAg immunoassay (chemiluminescent micropar-
ticle immunoassay) for the qualitative and quantitative
detection of HBsAg.
HSPA5 AND HSPA5 PROMOTER
ANALYSIS
RelA sites (model ID MA0107.1) were analyzed
using JASPAR with a relative proﬁle score threshold
of 85% for the HSPA5 (ENSG00000044574) and
hspa5 (ENSMUSG00000026864) genes with a 50
ﬂanking region of 1000 base pairs; gene structure and
predicted sites were visualized using the Integrative
Genomics Viewer (also see Supporting Information).
STATISTICAL ANALYSIS
Statistical analysis was performed with GraphPad
Prism software, version 6.0 (GraphPad Software).
Data are shown as means 6 standard error of the
mean, if not indicated differently. Statistical signiﬁ-
cance was determined using a two-tailed Student t
test. P < 0.05 was considered signiﬁcant (*P < 0.05,
**P < 0.01, ***P < 0.001).
Results
CANONICAL NF-jB SIGNALING IS
ACTIVATED IN LIVER
PARENCHYMAL CELLS OF
CHRONIC HBV PATIENTS AND
MICE EXPRESSING HBsAg
In patients chronically infected with HBV, includ-
ing in inactive carriers (hepatitis B e antigen-negative,
showing no signiﬁcant necroinﬂammation, and HBV
DNA <2000 IU/mL), we observed nuclear transloca-
tion of RelA/p65 (Fig. 1A and Supporting Table S1).
Nuclear translocation of RelA/p65 correlated with
grade of inﬂammatory activity in CHB, hepatitis C,
and nonalcoholic steatohepatitis (Fig. 1B; Supporting
Fig. S1A,B); however, also inactive HBV carriers show
RelA/p651 hepatocytes mainly in HBsAg-positive
areas (Fig. 1A). Thus, we asked whether NF-jB sig-
naling could play an oncogenic or protective role in
hepatocytes of chronically HBV-infected patients who
show no overt inﬂammation but express viral tran-
scripts at a high level.
In order to determine the role of canonical NF-jB
signaling in disease onset and HCC development due
to high expression and accumulation of HBsAgs in the
ER, we used the well-characterized transgenic mouse
model exhibiting hepatocyte-speciﬁc expression of L,
M, and S HBV surface proteins at high levels in the
absence of speciﬁc inﬂammation (Fig. 1C), referred to
as HBsAg1 animals.(13,14) These mice show liver cell
injury by 4 months and HCC (with an incidence of
approximately 50%) by 12-20 months due to accumu-
lation of HBV surface proteins.(13,14) Gradually
increasing liver damage over time was evident in
HBsAg1 mice, with signiﬁcantly elevated liver trans-
aminase levels (Fig. 1D). Interestingly, in HBsAg1
transgenic animals we detected RelA/p65-positive
hepatocyte nuclei, similar to human inactive CHB
samples (Fig. 1C; Supporting Fig. S2E-G). Activation
of canonical NF-jB signaling was conﬁrmed by elec-
trophoretic mobility shift assay, which showed
enhanced NF-jB DNA-binding activity in whole-
liver lysates of HBsAg1 transgenics (Fig. 1E).
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FIG. 1. Activated NF-jB signaling in CHB and HBsAg overexpression. (A) Detection of activated NF-jB signaling in hepatocytes
of chronically HBV-infected patients especially in areas of HBsAg expression, as determined by IHC for HBsAg and RelA/p65. This
ﬁnding was also apparent in patients with inactive CHB (HBV DNA <2000 IU/mL, no signiﬁcant necroinﬂammation [METAVIR
A1], hepatitis B e antigen negative; bar 5 100 lm). Lower panel shows magniﬁcation of RelA/p65-IHC (yellow arrows indicating
RelA/p65-positive hepatocytes; bar 5 10 lm). (B) Quantiﬁcation of RelA/p65-positive hepatocyte nuclei as a percentage of total
hepatocyte nuclei in patients with “inactive” and “active” hepatitis B as well as patients chronically infected with HCV, patients with
nonalcoholic steatohepatitis, and healthy liver tissue as control (left graph). Positive correlation of histological inﬂammatory stage
(METAVIR 0-3)/nonalcoholic steatohepatitis grading for lobular inﬂammation (based on part of nonalcoholic fatty liver disease activ-
ity score 0-3) with ﬁnding of RelA/p65-positive hepatocyte nuclei (percentage) (right graph; r and p values are shown in legend). (C)
HBsAg expression and activation of NF-jB in hepatocytes of HBsAg1 transgenic mice shown by IHC for HBsAg and RelA/p65
nuclear translocation (yellow arrows; bar 5 100 lm) and magniﬁcation (bar 5 10 lm). (D) Alanine aminotransferase and aspartate
aminotransferase levels were elevated in 8-week-old, 20-week-old, and 70-week-old HBsAg1 versus control mice (control n 5 10-26,
HBsAg1 n 5 13-28). (E) NF-jB DNA-binding activity was proven by electrophoretic mobility shift assay in liver extracts from 20-
week-old control and HBsAg1 mice. Sp1 electrophoretic mobility shift assay was performed as a control. (F) Expression of NF-jB
target genes TNFa and A20 determined by qPCR was up-regulated in livers from HBsAg1 mice (fold change; TNFa n 5 4, A20 n
5 6). Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; NAS, nonalcoholic fatty liver disease activity
score; NASH, nonalcoholic steatohepatitis.
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Moreover, mRNA expression of NF-jB target genes
such as Tnfa (tumor necrosis factor-a [TNFa]) and
Tnfaip3 (A20) was signiﬁcantly up-regulated in livers
of HBsAg1 livers (Fig. 1F). These data suggest that
overexpression of HBsAgs alone is sufﬁcient to induce
canonical NF-jB activation in hepatocytes. This is
consistent with our ﬁnding of canonical NF-jB activa-
tion in hepatocytes of patients expressing HBsAg with
inactive CHB and with previously reported activation
of canonical NF-jB signaling in CHB and subsequent
HCC development.(3-5)
HEPATOCYTE-SPECIFIC
INHIBITION OF CANONICAL
NF-jB INCREASES
HEPATOCELLULAR CARCINO-
GENESIS IN HBsAg TRANSGENIC
MICE
To determine whether NF-jB signaling inﬂuences
HCC formation in HBsAg transgenic livers, we
crossed HBsAg1 transgenic mice to mice expressing a
dominant negative form of IKK2/IKKb (IKK2KD) in
hepatocytes, resulting in inhibition of canonical NF-
jB signaling (IKK2KDHep mice). Transgenic domi-
nant negative IKK2 expression was repressed by doxy-
cycline administration in the drinking water until the
age of 3 weeks to rule out effects in liver organogenesis.
Removal of doxycycline at that time point led to liver-
speciﬁc induction of a luciferase reporter gene as well
as IKK2KD expression (Supporting Fig. S2A-C).
Activation of canonical NF-jB signaling in whole-
liver lysates of HBsAg1/IKK2KDHep double-
transgenic mice was decreased compared to HBsAg1
as shown by phosphorylated RelA/p65 western blot
(Supporting Fig. S2C,D). No RelA/p651 hepatocyte
nuclei were detectable after inhibition of canonical
NF-jB in HBsAg1/IKK2KDHep mice (Supporting
Fig. S2E-G), and mRNA expression of NF-jB target
genes such as Tnfa, Tnfaip3, Tnfsf14, and Tnfsf10 was
signiﬁcantly down-regulated compared to HBsAg1
and control animals (Supporting Fig. S2H).
Of note, inhibition of canonical NF-jB signaling in
HBsAg1/IKK2KDHep mice induced a dramatic
increase in tumor incidence, number, and size: HCC
of HBsAg1/IKK2KDHep mice was characterized by
large, macroscopically visible tumors compared to
HBsAg1 single-transgenic animals which displayed
small tumor nodules (Fig. 2A). Tumor incidence was
increased to 100% in HBsAg1/IKK2KDHep mice
compared to 50% in HBsAg single-transgenic mice
at 70 weeks (Fig. 2B). Furthermore, HBsAg1/
IKK2KDHep mice displayed a signiﬁcantly higher
number of tumor nodules and a larger maximum
tumor size (Fig. 2B). These ﬁndings were consistent
with an overall increase in liver weight and liver trans-
aminase levels (alanine aminotransferase and aspartate
aminotransferase) (Fig. 2C).
A thorough histological analysis of all tumors
showed several histological HCC subtypes in both
HBsAg1/IKK2KDHep and HBsAg1 mice (Fig. 2D;
Supporting Fig. S3B). RNA expression analysis of
proliferation and differentiation genes of tumor nod-
ules was performed and compared to control tissue of
semimalignant HCC of WHV/N-Myc2 transgenic
p53 heterozygous and poorly differentiated tumors of
WHV/N-Myc2 transgenic p53 knockout. HCC from
HBsAg1/IKK2KDHep mice frequently showed alpha-
fetoprotein expression and a more malignant pheno-
type in a 16-gene analysis (Fig. 2E). However, there
was no signiﬁcant difference in the number of Ki671
cells in HCC between genotypes (Supporting Fig.
S3C). Of note, analysis of 70-week-old IKK2KDHep
single-transgenic mice revealed small adenomas in one
of six animals (Supporting Fig. S3D).
These data suggest that canonical NF-jB signaling
is a crucial antitumorigenic factor in HCC develop-
ment in the context of high HBsAg expression, which
is in contrast to HCC that arises in the context of a
chronic inﬂammatory environment.(3,4)
INHIBITED CANONICAL NF-jB
SIGNALING IN HBsAg1
TRANSGENIC MICE DISRUPTS
COMPENSATORY LIVER
REGENERATION
Regarding the observed tumor-suppressive role of
NF-jB, we investigated whether NF-jB inhibition in
HBsAg1 mice enhances secondary inﬂammatory
responses in mice at 20 weeks (i.e., preneoplastic).
However, immunohistological staining for CD31 (T
lymphocytes) and F4/801 (macrophages, Kupffer cells)
revealed no signiﬁcant change in invading inﬂamma-
tory cells in HBsAg1/IKK2KDHep transgenic mice
compared to HBsAg1 transgenic mice (Fig. 3A), nor
did we detect a signiﬁcant increase in expression of the
inﬂammatory cytokine interleukin-6 (IL-6) in
HBsAg1, HBsAg1/IKK2KDHep, or control livers by
qPCR or enzyme-linked immunosorbent assay (Fig.
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FIG. 2. Expression of a dominant-negative form of IKK2 in the liver leads to enhanced HBsAg-induced tumorigenesis. (A) Macro-
scopic appearance of liver tumors in 70-week-old mice. *Small tumor nodules. Brackets and yellow arrows indicate massive tumors in
HBsAg1/IKK2KDHep mice (bar 5 1 cm). (B) Incidence of tumors (>1 mm) in 70-week-old mice, number of macroscopically appa-
rent tumor nodules (>1 mm), and maximal macroscopic tumor volume (HBsAg1 n 5 13, HBsAg1/IKK2KDHep n 5 6). (C) Ala-
nine aminotransferase and aspartate aminotransferase levels measured in 70-week-old mice (n 5 8-14). (D) Representative
hematoxylin and eosin and IHC staining for colIagen IV, GP73 (golph2), and alpha-fetoprotein displaying typical HCC features (bar
5 100 lm; dotted line marks HCC boarder). (E) Sixteen-gene analysis by qPCR of tumors derived from HBsAg1 and HBsAg1/
IKK2KDHep mice compared to semimalignant HCC from WHV/N-Myc2tg/p531/D mice and poorly differentiated tumors from
WHV/N-Myc2/p53D/D mice. (F) Western blot analysis for GP73 and b-tubulin as loading control. Abbreviations: AFP, alpha-
fetoprotein; ALT, alanine aminotransferase; AST, aspartate aminotransferase; Col IV, colIagen IV; HE, hematoxylin and eosin.
                                                                                                                                      
SUNAMI, RINGELHAN, ET AL. HEPATOLOGY, May 2016
1598
                                                                                                                                      
FIG. 3. Inhibition of canonical NF-jB signaling in HBsAg1 transgenic mice disrupts compensatory liver regeneration with concomi-
tant occurrence of ductular reactions. (A) IHC for CD3 (T lymphocytes) and F4/80 (macrophages/Kupffer cells) in livers of 20-week-
old mice (bar 5 100 lm) and morphometric quantiﬁcation of CD3-positive lymphocytes (percent of total cells) and F4/80-positive
area (control n 5 3, HBsAg1 and HBsAg1/IKK2KDHep n 5 7). (B) mRNA levels for Il6 by qPCR shown as fold change (control
n 5 4, HBsAg1 and HBsAg1/IKK2KDHep n 5 8). IL-6 protein level from liver lysates determined by enzyme-linked immunosor-
bent assay (n 5 7-10). (C) Serum alanine aminotransferase and aspartate aminotransferase levels of 20-week-old mice (control n 5
26, HBsAg1 n 5 28, IKK2KDHep n 5 10, and HBsAg1/IKK2KDHep n 5 8). (D) IHC for caspase-3 cleavage (bar 5 100 lm)
with morphometric quantiﬁcation (n 5 4-7). (E) IHC for Ki67 expression (bar 5 100 lm) with morphometric quantiﬁcation for
Ki67-positive hepatocytes (n 5 4-7). (F) Ductular reaction, characterized by IHC for cytokeratin 19 and relative mRNA expression of
cytokeratin 19 determined by qPCR (control n 5 3, HBsAg1 n 5 6, HBsAg1/IKK2KDHep n 5 5). Abbreviations: ALT, alanine
aminotransferase; AST, aspartate aminotransferase; CK19, cytokeratin 19.
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3B). In fact, Il6 mRNA expression was actually signiﬁ-
cantly reduced in HBsAg1/IKK2KDHep livers com-
pared to HBsAg1 mice. Moreover, NF-jB inhibition
in HBsAg1 livers did not further increase transami-
nase levels (Fig. 3C). These data argue against an
increased necroinﬂammatory environment as explana-
tion for the drastically increased HCC incidence in
HBsAg1/IKK2KDHep transgenic mice, which is in
contrast to the diethylnitrosamine or the hepatocyte-
speciﬁc NEMO knockout model.(5,33)
Hepatocyte apoptosis, as analyzed by cleaved
caspase-3 immunohistochemistry (IHC) at 20 weeks,
was frequently detected in HBsAg1 transgenic mice
and slightly increased after inhibiting canonical NF-
jB (Fig. 3D). IHC for Ki67 showed strong hepatocyte
proliferation in HBsAg1 single-transgenic mice, indi-
rectly indicating elevated hepatocyte apoptosis due to
HBsAg expression (Fig. 3E). Surprisingly, prolifera-
tion of hepatocytes was not further increased in
HBsAg1/IKK2KDHep animals (Fig. 3E).
Hematoxylin and eosin staining revealed an increase
in small cells in HBsAg1/IKK2KDHep livers which
were negative for immune cell markers and positive for
the biliary linage marker cytokeratin 19 (Fig. 3F), indi-
cating a ductular reaction (i.e., oval cell response).
INHIBITION OF CANONICAL
NF-jB SIGNALING LEADS TO A
DOWN-REGULATION OF THE
UPR MASTER REGULATOR
BINDING IMMUNOGLOBULIN
PROTEIN/78-KDA GLUCOSE-
REGULATED PROTEIN AND
ENHANCED ER STRESS
HBsAg was distributed unevenly throughout livers
and in the ER of hepatocytes when the canonical NF-
jB pathway was blocked (Fig. 4A,B). However, serum
HBsAg was unchanged in HBsAg1/IKK2KDHep
compared to HBsAg1 single-transgenic mice (Fig.
4C). This suggests that inhibition of canonical NF-jB
signaling inﬂuences HBsAg protein processing, possi-
bly due to increased ER stress, as overproduction of
the HBV large envelope polypeptide in HBsAg trans-
genic mice was previously shown to lead to accumula-
tion of ﬁlamentous HBV surface particles within the
ER of hepatocytes.(13)
We therefore measured mRNA expression of genes
known to be involved in ER stress, inﬂammation, and
DNA damage. In 20-week-old HBsAg1/IKK2KDHep
mice, expression of genes associated with ER stress
and the UPR were altered when compared to HBsAg1
single-transgenic and littermate control mice (Fig. 4D;
Supporting Fig. S4A). Among the most signiﬁcantly
down-regulated genes compared to HBsAg1 was
binding immunoglobulin protein (BiP)/78-kDa
glucose-regulated protein, a molecular chaperone of
the HSP70 family that acts as a master regulator of
newly synthesized protein folding (Fig. 4E).(19)
When aggregated proteins accumulate in the ER,
BiP determines whether unfolded or misfolded pro-
teins should be targeted to ER stress-associated degra-
dation and to promote cell survival or to direct cells
toward apoptosis.(34) Consistent with our gene expres-
sion analysis (Fig. 4E), we observed decreased BiP
protein expression by both western blotting and IHC
after NF-jB inhibition in HBsAg1/IKK2KDHep mice
compared to single-transgenic HBsAg1 or control
mice (Fig. 4E; Supporting Fig. S5D).
These data suggest that inhibiting canonical NF-jB
signaling in hepatocytes in the context of HBsAg
expression leads to decreased hepatic BiP and thus dis-
rupted ER stress sensing. Promoter analysis using
JASPAR predicted with 85% probability that the pro-
moter region of human and mouse HSPA5/hspa5 genes
encoding BiP lacked any NF-jB-binding site (Sup-
porting Fig. S5E; Supporting Table S2). Furthermore,
BiP was shown not to be a direct NF-jB target
gene,(27) and normal expression was detected by IHC
after NF-jB inhibition in IKK2KDHep single-
transgenic mice (Supporting Fig. S5A-C), arguing for
an indirect effect of NF-jB signaling on BiP expres-
sion during prolonged ER stress.
ER transmembrane signal transducers such as acti-
vating transcription factor 6 (ATF6) and PERK are
released from BiP upon accumulation of unfolded pro-
teins. Free ATF6 translocates from the ER to the
Golgi, where it is proteolytically processed.(35) PERK
dissociation from BiP triggers activation of eIF2 by
phosphorylation and ATF4 expression. These signal-
ing pathways regulate ER stress-associated gene
expression, including the cell death regulator
CHOP.(20)
We consistently observed ER stress signaling by sig-
niﬁcantly increased processed ATF6 protein, enhanced
eIF2 phosphorylation, as well as elevated ATF4 and
CHOP expression in HBsAg1/IKK2KDHep mice
(Fig. 4F; Supporting Fig. S5F).
Therefore, we conclude that canonical NF-jB plays
an important role in controlling the UPR. Inhibition
of NF-jB in mice expressing HBsAgs at high levels
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FIG. 4. Inhibition of NF-jB signaling leads to prolonged ER stress signaling and reduced expression of the UPR regulator BiP. (A)
Representative IHC for HBsAg in HBsAg1 and HBsAg1/IKK2KDHep livers at 20 weeks of age (bar 5 100 lm). (B) Representative
immunoﬂuorescence staining of whole liver tissue of HBsAg1 and HBsAg1/IKK2KDHep mice showing HBsAg accumulation (red)
in the ER of hepatocytes labeled with the ER marker P4HB (green). 40,6-Diamidino-2-phenylindole (blue) shows nuclei of cells, and
overlay displays colocalization (bar 5 10 lm). (C) Quantitative serum analysis of HBsAg levels in HBsAg1 versus HBsAg1/
IKK2KDHep mice (control n 5 3, HBsAg1 n 5 8, and HBsAg1/IKK2KDHep n 5 5). (D) mRNA expression levels of genes
involved in apoptosis, DNA damage, and UPR control; means of fold change (of n 5 3-6 animals per group) were summarized in a
heat map. Statistical analysis is shown between HBsAg1 and HBsAg1/IKK2KDHep. (E) IHC for BiP expression in HBsAg1 and
HBsAg1/IKK2KDHep livers (bar 5 100 lm) with morphometric quantiﬁcation of IHC for BiP (left graph, control n 5 3, HBsAg1
and HBsAg1/IKK2KDHep n 5 6), mRNA expression of BiP determined by qPCR (right graph, n 5 6), and western blot analysis of
whole-liver extracts using antibodies against BiP and b-tubulin as loading control. (F) Western blot analysis of factors involved in the
UPR, using antibodies against ATF6, eIF2, phospho-eIF2, ATF4, CHOP, and b-tubulin as a loading control (for quantiﬁcation see
Supporting Figs. S5 and S6).
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leads to improper expression of the ER stress master
regulator BiP and uncontrolled activation of the UPR
signaling pathways.
HBsAg1/IKK2KDHep
HEPATOCYTES DISPLAY CHOP
OVEREXPRESSION AND G1/
S-PHASE CELL CYCLE ARREST
We observed excessively increased CHOP expres-
sion in HBsAg1/IKK2KDHep mice by IHC analyses
(Fig. 5A). Notably, NF-jB inhibition alone in
IKK2KDHep single-transgenic control mice does not
signiﬁcantly change CHOP expression (Supporting
Fig. S6A-C). CHOP not only is a key regulator of ER
stress-associated apoptosis but also attenuates cellular
proliferation.(36,37) Because HBsAg1/IKK2KDHep
hepatocytes showed an uncontrolled UPR and lacked
any further increase in ki671 (Fig. 3E; Supporting Fig.
S6D), did not show signiﬁcant increased apoptosis
(Fig. 3D), yet did show the emergence of ductular
reactions (Fig. 3F), we asked whether there is a defect
in cell cycle progression. Both HBsAg1 and HBsAg1/
IKK2KDHep mice showed increased cyclin D1 expres-
sion in hepatocytes at 20 weeks as shown by IHC and
western blot analyses (Fig. 5B,C). Conversely, expres-
sion of cyclin E and CDK2 was decreased in
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FIG. 5. Hepatocytes of HBsAg1/IKK2KDHep mice display CHOP overexpression and G1/S-phase cell cycle arrest. (A) Overexpres-
sion of CHOP in HBsAg1/IKK2KDHep livers shown by IHC (bar 5 100 lm). (B) IHC analysis for cyclin D1 shows expression in
hepatocytes (bar 5 100 lm) and morphometric quantiﬁcation of cyclin D11 hepatocyte nuclei (n 5 4-6). (C) Expression of factors
involved in cell cycle control analyzed by western blot in livers using antibodies against cyclin D1, CDK4, CDK6, cyclin E1, and
CDK2. (D) Expression of cell cycle inhibitors p16, p27, and b-tubulin as a loading control in western blot (for quantiﬁcation, see
Supporting Fig. S6).
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HBsAg1/IKK2KDHep livers compared to HBsAg1
(Fig. 5C; Supporting Fig. S6E), indicative of a late
G1-phase cell cycle arrest.
Because overexpression of CHOP can lead to G1/S-
phase cell cycle arrest,(37) we analyzed expression of
cell cycle inhibitors. We found elevated p27/Kip1 and
p16/CDKNA2 in HBsAg1/IKK2KDHep livers com-
pared to HBsAg1 or control (Fig. 5D; Supporting
Fig. S6E), resembling well-known cell cycle inhibitors
activated by cellular stress-blocking cyclin D/CDK4
and CDK2 activity.(38,39) These data suggest that inhi-
bition of canonical NF-jB signaling in hepatocytes
expressing high levels of HBsAg leads to CHOP over-
expression and G1/S-phase cell cycle arrest, indicating
severe cellular stress and inadequate liver regeneration
in hepatocytes due to uncontrolled ER stress.
PROLONGED ER STRESS IN
HEPATOCYTES PROMOTES
ACCUMULATION OF DNA
DAMAGE AND INCREASED HCC
INCIDENCE
Even though HBsAg1/IKK2KDHep hepatocytes
show prolonged, uncontrolled ER stress with accumu-
lation of CHOP and cell cycle arrest, ATF3 expression
and nuclear ATF3-positive hepatocytes were reduced
compared to HBsAg1 mice (Fig. 6A-C). ATF3 is an
adaptive response gene induced by various cellular
stress stimuli to activate or repress gene expression and
to act as a tumor suppressor by promoting cell death
and suppressing cell cycle progression. As a conse-
quence of this uncontrolled cellular stress response
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FIG. 6. Attenuated ATF3 expression and accumulation of DNA damage due to uncontrolled ER stress. (A) IHC for ATF3 shows
reduced nuclear staining in hepatocytes after NF-jB inhibition (bar 5 100 lm). (B) Morphometric quantiﬁcation of ATF31 hepato-
cyte nuclei, and (C) relative mRNA expression of ATF3 determined by qPCR (control n 5 3, HBsAg1 and HBsAg1/IKK2KDHep
n 5 6). (D) Morphometric quantiﬁcation of nuclear positivity for the DNA damage marker cH2AX (n 5 4), and (E) IHC for the
DNA-damage marker cH2AX and magniﬁcations displaying positive hepatocytes (arrowheads; bar 5 100 lm).
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after NF-jB inhibition, high levels of DNA damage
in hepatocytes were already detected at 20 weeks of age
in HBsAg1/IKK2KDHep mice, as shown by serine-
139-phosphorylated cH2AX levels (Fig. 6D,E).
We conclude that, in the case of HBsAg-driven
HCC, canonical NF-jB signaling plays an indispensa-
ble role in properly controlling the UPR. The absence
of canonical NF-jB signaling leads to a prolonged,
uncontrolled UPR with loss of the UPR master regula-
tor BiP, overexpression of CHOP, and cell cycle arrest,
indicative of increased cellular stress. This is accompa-
nied by accumulation of DNA damage and subsequent
100% HCC incidence.
Discussion
Here, we identify a novel role of NF-jB signaling in
controlling ER stress response, which acts as a tumor-
suppressor in HBV protein-driven HCC development.
We found that NF-jB is essential for proper UPR
control and BiP expression. Moreover, loss of NF-jB
causes disrupted UPR with CHOP overexpression,
induction of cell cycle arrest in hepatocytes, and occur-
rence of ductular reactions. Finally, due to prolonged
ER stress, DNA damage accumulates in hepatocytes,
culminating in markedly enhanced HBsAg-driven
hepatocellular carcinogenesis.
Human HCC is typically preceded by chronic
inﬂammation, cell death, and compensatory liver pro-
liferation; however, in CHB infection HCC can occur
in the absence of cirrhosis and severe necroinﬂamma-
tion. In so-called inactive CHB patients HCCs still
occur, despite efﬁcient suppression of HBV viremia
and necroinﬂammation by nucleos(t)ide analogue ther-
apy, particularly in patients with high HBsAg levels.(9-
11) In addition to HBV DNA integration and effects
of the enigmatic HBV x-protein, ground glass hepato-
cytes, containing accumulated HBV surface proteins,
as well as preS1/2 mutants, C-terminally truncated M
protein and overexpression of HBV large surface pro-
teins are found in chronically HBV-infected patients
and exert oncogenic functions.(15-17) Most impor-
tantly, observations from CHB patients under condi-
tions of immune suppression and in HBV transgenic
mouse models suggest that in the absence of adaptive
immune responses and NF-jB signaling, cellular stress
induced by HBV may also lead to development of liver
disease and HCC.(21-23)
In the case of the HBsAg-driven liver cancer model,
where HBsAg is expressed as a transgene and is not
detected by the host immune system due to central
immune tolerance,(6) we did not detect secondary
inﬂammation, increased transaminases, or increased
IL6 levels after NF-jB inhibition (Fig. 3), which was
reported in other models showing an antitumorigenic
role for NF-jB signaling using hepatocyte-speciﬁc
deletion of NEMO or IKK2.(5,33)
Almost three dacades ago, studies demonstrated the
oncogenic potential of overexpressed HBV envelope
polypeptides and accumulation of ﬁlamentous HBsAg
particles within the ER as a potential mechanism.(13,14)
Accumulation of unfolded/misfolded proteins activates
intracellular signaling pathways associated with ER
stress. This is buffered by activation of the UPR, a
homeostatic signaling network responsible for recover-
ing ER function, or if this fails, triggering apoptosis.(34)
In ER stress sensing and UPR, BiP is the central
regulator; and in the current study, we demonstrate
that inhibition of canonical NF-jB signaling leads to
inadequate expression of BiP in the HBsAg model
(Fig. 4E; Supporting Fig. S5). It has been reported
that NF-jB does not induce BiP expression(27); how-
ever, another study suggested that the UPR induces
RelA/p65 binding to the BiP promoter region.(28) We
did not observe any NF-jB-binding site in the BiP
promoter, and BiP is not directly down-regulated due
to loss of NF-jB signaling as homeostatic BiP expres-
sion was not altered in IKK2KDHep control animals,
indicating indirect regulation of BiP by NF-jB. We
clearly demonstrate that NF-jB signaling is required
for UPR control and sustained BiP expression. More-
over, inhibition of canonical NF-jB signaling not only
attenuates BiP expression but also leads to overexpres-
sion of CHOP (growth arrest and DNA damage-
inducible gene 153) in association with activation of
the ATF6 and eIF2/ATF4 pathways in HBsAg1
mice, thus generating a sustained ER stress response
due to HBsAg expression. Consistent with our results,
it has been shown that BiP overexpression down-
regulates CHOP(40); vice versa, down-regulation of
BiP is associated with processing of ATF6 (activation)
and consequent overexpression of ATF4 and CHOP.
Overexpression of CHOP in hepatocytes after NF-jB
inhibition was found in almost all hepatocytes; how-
ever, no concomitant signiﬁcant increase in apoptotic
hepatocytes was detectable (Fig. 4).
CHOP is a key regulator of ER stress-associated
apoptosis and is associated with liver cancer develop-
ment; however, its precise role is not yet clear.(41)
CHOP expression was reported to be up-regulated in
human HCC. In addition, complete deletion of Ddit3
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(encoding CHOP) in mice confers resistance to chem-
ical hepatocarcinogenesis by attenuating both apoptosis
and cellular proliferation.(36) Furthermore, CHOP
overexpression blocks cells from progressing from the
G1 to the S phase by dimerizing with other CCAAT/
enhancer binding proteins and being directed away
from “classical” CCAAT/enhancer binding protein
sites.(37)
Inadequate liver regeneration was associated with
sustained CHOP expression and, in the case of NF-
jB inhibition in our HBsAg1 transgenic model, was
accompanied by overexpression of p27 (Fig. 5). This is
consistent with the known activation of cell cycle
inhibitors due to cellular stressors, such as prolonged
ER stress. The cell cycle inhibitors INK4a
(CDKNA2/p16) and p27 (Kip1) block cyclin D/
CDK4 and CDK2 activity,(38,39) which may explain
the inability of hepatocytes to initiate proper compen-
satory proliferation as well as the occurrence of ductu-
lar reactions, suggesting inadequate liver regeneration.
Intrahepatic ductular reactions due to impaired hepa-
tocyte proliferation have been described. Oval cells
were initially believed to serve as a substitute progeni-
tor compartment for both cholangiocytes and hepato-
cytes if acute or chronic liver injury compromises self-
duplication of the mature epithelial cells.(42) However,
recent data demonstrate that the adult liver progenitor
compartment within biliary compartment-derived
ductular reactions does not function to replenish a sig-
niﬁcant proportion of hepatocytes, and ductular cells
are not the main source of malignant transformation in
HCC(43,44) but rather indicate severe liver damage.
Consistent with a disrupted UPR response and loss
of ER stress control after NF-jB inhibition in the
HBsAg model, expression of the general cellular stress
response factor ATF3 was decreased in comparison to
HBsAg1 mice (Fig. 6). ATF3, an adaptive-response
gene induced by cellular stress, represses cyclinD1 and
CHOP expression. Due to its tumor-suppressor func-
tions, attenuated ATF3 is likely to contribute to
increased HCC development.(45) Conversely, overex-
pression of ATF3 in tumor tissue was reported to con-
tribute to chemoresistance and invasive growths.(46)
In our model we propose that lack of canonical NF-
jB signaling disrupts cellular stress responses that
would be initiated by ER stress and aggravates pathol-
ogy due to enhanced cellular stress. Cellular stressors
such as prolonged ER stress are known to increase the
sporadic occurrence of DNA damage. Damage that
occurs within stressed cells must be tightly controlled
to prevent either loss of function or the clonal persist-
ence of oncogenic mutations that increase the risk of
tumorigenesis.(47) This is consistent with our ﬁnding
of signiﬁcantly increased DNA damage already at 20
weeks of age due to loss of UPR control after NF-jB
inhibition in HBsAg1 mice. These events ﬁnally cul-
minate in a 100% incidence of hepatocellular
carcinogenesis.
However, the mechanism identiﬁed here may not be
speciﬁc to HBV as ER stress also has been shown to
be potentially oncogenic in HCV and nonalcoholic
steatohepatitis.(29,48,49) Nevertheless, HCV-infected
human livers usually show no apparent induction of
UPR-responsive genes, which is in line with CHB
patients.(50) As in HBsAg1 mice, we did not detect
signiﬁcant CHOP up-regulation in human samples
(data not shown) as ER stress is normally tightly con-
trolled. This underlines the importance of intact NF-
jB signaling in ER stress.
Further studies are needed to determine whether
these mechanisms are applicable only to HBsAg-
driven or also to general ER stress-associated tumor
models. Nevertheless, our study highlights a critical
role of NF-jB for UPR control in liver cancer
development.
Thus, any treatment inhibiting NF-jB signaling in
patients harboring CHB is best avoided, and in gen-
eral, previously proposed therapeutic approaches tar-
geting NF-jB signaling in HCC development may
not be applicable in the context of CHB infection and
ER stress conditions.
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